Trump’s 100% tariffs on generic drugs to reshape US pharma
President Trump announced 100% tariffs on imported generic pharmaceutical drugs, targeting a sector that supplies 90% of US prescriptions. The move, set for August 2028, is already drawing fierce industry pushback over patient costs.
